Search - tctmd.com

Displaying 421 - 440 of 684

Sort: Relevancy | Date

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

Presentation TCT 2018

Clinical Trials for Short DAPT: FDA Perspective

Presenter: Christopher J Popma

September 22, 2018

Presentation TCT 2018

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma

September 22, 2018

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years

Presenter: Jay S. Giri, Sahil A. Parikh

September 22, 2018

Presentation TCT 2018

TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials

Presenter: Michael A. Kutcher, Tullio Palmerini, Ioanna Kosmidou

September 21, 2018

Presentation TCT 2018

TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

Presenter: Alexandre Abizaid, Didier Carrié, David E. Kandzari

September 21, 2018

Presentation TCT 2018

Update of the NeoVas BRS Clinical Trials

Presenter: Runlin Gao, Martin B. Leon, Yaling Han

September 21, 2018

Presentation SCAD 2018

How should we design future SCAD trials?

Presenter: Karin H Humphries

September 08, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Presenter: Scott Lim

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation ISET 2018

Update on Stroke Management: The Latest Clinical Trials

Presenter: Guillherme Dabus

February 03, 2018

Presentation Cardiovascular Interventions 2017

How Me The Data: Key Clinical Trials of 2017

Presenter: Curtiss T. Stinis

November 09, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Advertisement

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Clinical Trials for Short DAPT: FDA Perspective

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years

TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials

TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

Update of the NeoVas BRS Clinical Trials

How should we design future SCAD trials?

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

UK All-Comers

Evolut R Low-Risk

Partner 3 Low-Risk

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Update on Stroke Management: The Latest Clinical Trials

How Me The Data: Key Clinical Trials of 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content